Publisher
Springer Science and Business Media LLC
Reference5 articles.
1. Di Serafino M, Iacobellis F, Ronza R, et al. Hepatobiliary-specific magnetic resonance contrast agents: role in biliary trauma. Gland Surg. 2023;12(10):1425–33.
2. Greiser J, Winkens T, Perkas O, Kuehnel C, Weigand W, Freesmeyer M. Automated GMP production and preclinical evaluation of [(68)Ga]Ga-TEoS-DAZA and [(68)Ga]Ga-TMoS-DAZA. Pharmaceutics 2022;14(12).
3. Freesmeyer M, Drescher R, Kuhnel C, Guhne F, Greiser J. Hepatobiliary excretion PET/CT with 68Ga-TAoS-DAZA to evaluate bile Duct Patency. Clin Nucl Med. 2022;47(1):59–60.
4. Medicinal Products Act Germany in the version published on 12 December 2005. (Federal Law Gazette [BGBl.]) Part I p. 3394, last amended by Article 1 of the Act of 19 July 2023 (Federal Law Gazette 2023 I no. 197).
5. Bernstine H, Braun M, Yefremov N, et al. FDG PET/CT early dynamic blood flow and late standardized uptake value determination in hepatocellular carcinoma. Radiology. 2011;260(2):503–10.